TGTX ▼ -1.5% - TG Therapeutics, Inc.
$TGTX - TG Therapeutics Announces Phase 1 Data Evaluating Azer-cel in Progressive Multiple Sclerosis in a Late-Breaking Oral Presentation at MSToronto2026
23-OCT-2026 10:57 AM ET
Share this post
More filings for $TGTX
TGTX ▼ -1.5% - TG Therapeutics, Inc.Oct 23, 2026TGTX ▲ +0.5% - TG Therapeutics, Inc.Oct 21, 2026TGTX ▼ -0.1% - TG Therapeutics, Inc.Oct 21, 2026TGTX ▼ -0.7% - TG Therapeutics, Inc.Oct 12, 2026TGTX ▼ -0.7% - TG Therapeutics, Inc.Oct 12, 2026TGTX ▼ -0.0% - TG Therapeutics, Inc.Oct 8, 2026
View full $TGTX filing history →💬 Comments
Loading comments…
Leave a comment